Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 10, 2023.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
The FDA was busy in January 2023, making a number of decisions on potential new therapeutic agents, clearing a couple clinical trial holds, issuing some guidance on stroke risk, and clearing new devices, among other actions. With all the treatments that have progressed through the pipeline of clinical development, the NeurologyLive® team has been hard at work covering all the agency movements to make sure you are up to date on the latest news in neurology.
In episode 15 of this Peer Exchange, the panel of experts in dementia share data on lecanemab, an anti-amyloid beta antibody, that was presented at CTAD 2022. The NeurologyLive® series panel features Marwan Sabbagh, MD; Alireza Atri, MD, PhD; Sharon Cohen, MD, FRCPC; and Eric McDade, DO.
In the latest edition of our in-depth Q&A series, the medical director of stroke at Fairview Hospital, an affiliate of Cleveland Clinic, provided perspective on a new intervention that improves communication and reduces hospital readmission for stroke. Additionally, she discussed the clinical applicability of this intervention, and whether it can be widely used in centers across the country.
Episode 82 of the Mind Moments podcast features an exclusive interview with Carolina Ferreira Atuesta, MD, MSc, a scientific researcher and clinical data manager at the Icahn School of Medicine at Mount Sinai. She spoke about research she and colleagues recently presented at the American Epilepsy Society Annual Meeting on poststroke epilepsy, the ongoing clinical efforts to manage seizures occurring after stroke, what studies still need to explore, and more.
The assistant professor of neurology at Yale School of Medicine sat down with NeurologyLive® in an interview to talk about the relaunch of MGFA’s patient registry. He spoke about the implications and the significance of research with using the registry to recruit patients with myasthenia gravis in clinical trials. [WATCH TIME: 3 minutes]